Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Beacon Pharmaceuticals
85 High Street, Tunbridge Wells, TN1 1YG
Telephone: +44 (0)1892 600 930
Fax: +44 (0)1892 600 937
WWW: http://www.beaconpharma.co.uk
Medical Information e-mail: info@beaconpharma.co.uk

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Summary of Product Characteristics last updated on the eMC: 25/11/2011
SPC Clasteon 400mg Capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 25/11/2011 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.4 - Special warnings and precautions for Use
  • Change to section 4.8 - Undesirable Effects
Date of revision of text on the SPC:   04-Nov-2011
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Section 4.4 - Section added titled "Atypical fractures of the femur"

Section 4.8 - added section on post-marketing experience
Updated on 23/09/2011 and displayed until 25/11/2011
Reasons for adding or updating:
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   13-Sep-2011
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Renewal of MA
Updated on 29/07/2010 and displayed until 23/09/2011
Reasons for adding or updating:
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.4 - Special warnings and precautions for Use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Pregnancy and Lactation
  • Change to section 4.8 - Undesirable Effects
  • Change to section 4.9 - Overdose
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   20-May-2010
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
All changes are bring the SPC in line with the brandleader product.
Updated on 18/06/2007 and displayed until 29/07/2010
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 18/06/2007 and displayed until 18/06/2007
Reasons for adding or updating:
  • New SPC for new product
  • Pending awaiting re-submission

Active Ingredients/Generics

 
  sodium clodronate tetrahydrate